Analytical Strategies for Peptide & Protein Therapeutics
A practical seminar designed for analytical specialists working with therapeutic Peptides & Proteins in CMC, Analytical Development and QC. Specialists for synthesis and purification will also benefit from the presented innovations and analytical workflows.
Why this seminar
AbbVie’s analytical organizations support development from early candidates through method transition to commercial labs, where robustness, clarity, and reproducibility reduce risk. Next generation peptides and proteins are promising therapeutics, but represent novel analytical challenges due to high molecular complexity.
This seminar is built to provide starting points for method development, help you reduce method rework, strengthen decision-ready packages.
What you’ll get
- A clear playbook for choosing LC separation modes for challenging peptide and protein modalities and related product and process impurities.
- A streamlined path to quantitative LC-MS/MS for peptides—including practical guidance for multiply charged analytes and faster MRM setup.
- More decision-ready insight on aggregation / heterogeneity using SEC-MALS and DLS when relative methods aren’t enough.
- Faster, low-volume routes to particle insight (high-throughput particle characterization concepts such as BMI/SIMI) to surface risks earlier.
- Insights into novel LC separation techniques and Charge Detection Mass Spectrometry (CDMS) for very large, highly heterogeneous species (viral vectors, nucleic acids, complexes) when conventional tools hit their limits.
🗓️ Date: February 18, 2026
🕗 Time: 1:30 PM-4:10 PM CET
📍 Location: AbbVie, Auditorium, Building 11, Knollstraße 50, 67061 Ludwigshafen am Rhein
